PDF is committed to using your funds efficiently to support our mission. To see how funds are spent, browse our financial information.
From the Blog: Northera Approved by the FDA
- Feb 23 2014
The US Food and Drug Administration has signaled that it will approve droxidopa (Northera™) for the treatment of a form of low blood pressure affecting people with certain conditions including Parkinson's disease.
However, James Beck, Ph.D., PDF's Vice President, Scientific Affairs, notes, "the FDA approval did not come lightly and several issues remain surrounding the use of droxidopa."
What are they? Find out in his blog on the topic.
Source Date: Feb 23 2014